Literature DB >> 32031285

The role of nucleolar spindle-associated protein 1 in human ovarian cancer.

Yuyang Zhang1, Kate Huang2, Huihua Cai3, Siping Chen3, Donghua Sun3, Pengfei Jiang4.   

Abstract

Ovarian cancer (OC) is one of the deadliest malignancies of the female reproductive system. The present study focused on the role of Nucleolar spindle-associated protein 1 (NuSAP1) in OC. Relative expression of NuSAP1 was detected in OC tissues as well as cells. After knocking down NuSAP1 with lentivirus-mediated shRNA and verifying the knockdown efficiency via quantitative real-time polymerase chain reaction and Western blot assays, the cell proliferation, apoptosis, and cell cycle were determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, colony formation, and flow cytometry, respectively. Transwell assay was conducted to detect the migration and invasion of OC cells. It was showed that NuSAP1 was abundantly expressed in OC tissues and cell lines. After knocking down NuSAP1 in OC cells, in addition to significantly inhibiting proliferation and colony forming ability, it also promotes apoptosis and affects cell cycle distribution. Moreover, cells in the shNuSAP1 group showed significantly suppressed migration and invasion ability compared with that in the shCtrl group. In conclusion, NuSAP1 may act as an oncogenic factor in OC and therefore might serve as an indicator for prognosis and therapeutic target for OC treatment.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  NuSAP1; apoptosis; metastasis; ovarian cancer; proliferation

Mesh:

Substances:

Year:  2020        PMID: 32031285     DOI: 10.1002/jcb.29661

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.

Authors:  Tiantian Gao; Lei Zhao; Fan Zhang; Conghui Cao; Shuting Fan; Xiaoguang Shi
Journal:  World J Surg Oncol       Date:  2022-06-16       Impact factor: 3.253

2.  Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.

Authors:  Rui Gou; Mingjun Zheng; Yuexin Hu; Lingling Gao; Shuang Wang; Ouxuan Liu; Xiao Li; Liancheng Zhu; Juanjuan Liu; Bei Lin
Journal:  BMC Cancer       Date:  2022-06-23       Impact factor: 4.638

3.  GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer.

Authors:  Yan Huang; Yixuan Liu; Keyu Zhu; Xiaolu Ma; Renquan Lu; Meiqin Zhang
Journal:  Cancer Manag Res       Date:  2021-01-19       Impact factor: 3.989

4.  Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.

Authors:  Min Wei; Xuefei Bai; Qiaomei Dong
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.